U.S. 3 Year Treasury Note-0.7690 3.8960% U.S. 5 Year Treasury Note-0.8360 3.9940% U.S. 7 Year Treasury Note-0.9130 4.1820% ...
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results